Engineered to satisfy stringent international guidelines (OECD 412, 413, 433) and domestic regulatory safety benchmarks (BPOM), our flagship inhalation exposure platforms deliver unmatched stability, dose reproducibility, and continuous animal welfare management.
Navigating Environmental Challenges, Rapid Industrialization, and Modern Preclinical Pharmaceutical Modernization in Southeast Asia's Largest Economy.
Preclinical facilities across West Java, Jakarta, and East Java are aggressively upgrading to international GLP standards to facilitate export-grade drug screening and chemical toxicological clearances.
From seasonal peatland wildfire haze in Sumatra and Kalimantan to urban vehicular emissions in Greater Jakarta (Jabodetabek), real-time online enriched particulate exposure simulation is vital.
Indonesia's historic traditional herbal medicine framework is undergoing rigorous scientific validation, demanding advanced inhaled phytopharmaceutical safety profiles and pharmacokinetic data.
The Republic of Indonesia represents one of the fastest-growing industrial landscapes in Southeast Asia. As extensive nickel processing plants, coal generation clusters, petrochemical hubs in Banten and East Java, and expansive mining infrastructures in Sulawesi and Kalimantan continue to scale, the necessity for occupational health monitoring and respiratory toxicology testing has reached historic highs. In Vivo Inhalation Exposure technology plays an indispensable role in defining precise occupational exposure limits (OELs), simulating mine dust exposure (silica, mineral particles), and establishing safety baselines for industrial workers.
Simultaneously, the Indonesian National Research and Innovation Agency (Badan Riset dan Inovasi Nasional - BRIN), alongside leading academic institutions like Universitas Indonesia (UI), Institut Teknologi Bandung (ITB), and Universitas Gadjah Mada (UGM), are prioritizing targeted respiratory therapy studies, particulate matter pathogenesis, and infectious bio-aerosol research. To achieve reproducible, publishable, and globally recognized scientific outcomes, research institutions require cutting-edge inhalation exposure systems characterized by strict aerodynamic control, uniform concentration gradients, and comprehensive safety containment.
Key Strategic Focus: Modern in vivo inhalation toxicology empowers Indonesian researchers to move beyond traditional oral gavage and subcutaneous testing, directly delivering dry powders, liquid mists, and gaseous analytes straight to pulmonary target zones under physiologically regulated parameters.
Addressing Localized Environmental, Agricultural, and Pharmaceutical Research Demands.
During dry El Niño spells, peatland forest fires in central Kalimantan and Riau produce dense transboundary haze enriched with volatile organic compounds (VOCs), black carbon, carbon monoxide, and ultra-fine ash. Standard toxicological chambers fail to handle the complex physicochemical behavior of such aerosols. Our PM2.5 Online Enriched Rodent Exposure Platforms allow environmental laboratories in Indonesia to capture ambient atmospheric aerosols, concentrate them through real-time virtual impactors, and expose rodent cohorts without altering the original photochemical state of the pollutants. This facilitates breakthrough research on pulmonary fibrosis, cardiovascular strain, and neurodegenerative impacts directly attributed to regional haze.
Indonesia boasts one of the richest biological biodiversity reserves globally. Herbal remedies derived from Curcuma xanthorrhiza (Temulawak), red ginger, and Andrographis paniculata (Sambiloto) are currently explored for inhalation administration to treat pulmonary tuberculosis, lung inflammation, and asthma. Delivering poorly soluble botanical extracts into animal lungs requires precision dry powder dispersion (Wright dust feeders) or ultra-fine ultrasonic liquid nebulization. With our Multi-concentration Nose-only Systems, researchers can achieve consistent mass median aerodynamic diameters (MMAD 1-3 μm), enabling targeted alveolar deposition and accurate pharmacokinetic/pharmacodynamic (PK/PD) assessments.
Tropical infectious agents, including tuberculosis, avian influenza strains (H5N1), and newly emerging viral pathogens, pose constant surveillance challenges in equatorial zones. Evaluating aerosol-borne transmissibility, mucosal vaccines, and anti-infective mists requires absolute negative-pressure secondary containment. The Biosafety Nose-only Exposure System integrates high-efficiency particulate air (HEPA H14) filtration, automated pressure balance algorithms, and sealed glovebox integration, safeguarding laboratory personnel while producing reproducible aerosol viral titers in experimental subjects.
Indonesia's vast agricultural footprint—encompassing palm oil, coffee, tea, and rubber plantations—demands intensive pesticide management. Regulatory oversight overseen by the Ministry of Agriculture and BPOM requires comprehensive 28-day and 90-day sub-chronic inhalation toxicity testing for agrochemical sprays. Coupled with our Fully Automated QuEChERS System for residue extraction, laboratories can execute complete workflows: from active ingredient aerosol exposure to metabolic degradation mapping and bioaccumulation analysis in non-target organs.
Eliminating Exposure Bias and Ensuring Absolute Uniformity across Every Exposure Port.
Our nose-only exposure manifolds utilize dual concentric flow architecture. Fresh, test-substance-laden aerosol flows continuously down the center chamber, passes each animal's nasal port, and is instantly evacuated via peripheral exhaust manifolds. This eliminates rebreathing of exhaled CO₂ and avoids secondary dermal or fur ingestion.
Equipped with online photometers, quartz crystal microbalances (QCM), and continuous oxygen/carbon dioxide sensors, our exposure suites calculate accurate real-time inhaled doses (deposited dose in μg/g body weight) based on dynamic animal plethysmography inputs.
From mice, rats, and guinea pigs to non-human primates (cynomolgus monkeys) and canines, interchangeable restraint tubes and customized ergonomic face masks ensure minimal animal restraint stress, maintaining physiological breathing frequencies throughout prolonged exposure regimens.
Multi-concentration Nose-only Inhalation Exposure System for Rodents
Canine Nose-only Exposure System
PM2.5 Online Enriched Rodent Whole-body Exposure System
Biosafety Nose-only Exposure System for Rodents
Nose-only Exposure System for Rodents
Dynamic Whole-body Exposure System for Rodents
Non-human Primate Nose-only Exposure System
In Vitro-In Vivo Correlation Test System (IVIVC)
Localized Calibration, Technical Consulting, and Turnkey Preclinical Inhalation Installation.
As Indonesia accelerates its national health sovereignty roadmap under the Ministry of Health (Kemenkes) and modernizes biomedical research across centers in Java, Bali, and Sumatra, having accessible, robust, and highly reliable in vivo inhalation infrastructure is essential. Inhalation exposure remains the gold-standard pathway for characterizing toxicological thresholds, evaluating inhaled therapies for pulmonary tuberculosis and asthma, and validating consumer chemical safety.
Our instruments provide comprehensive support throughout system selection, aerosol generation engineering (liquid atomization, dry powder feeding, condensation mono-disperse generation), computational fluid dynamics (CFD) chamber verification, and on-site qualification (IQ/OQ/PQ). By bridging in vitro cascade impactor testing (NGI) with realistic in vivo animal deposition via our proprietary In Vitro-In Vivo Correlation Test System (IVIVC), laboratories across Indonesia can reduce preclinical trial turnaround times, guarantee absolute regulatory compliance with BPOM, US FDA, and OECD directives, and lead Southeast Asia toward scientific excellence.